
GLP-1 receptor agonist
TopicHeard in 8 episodes across 7 shows since Aug 2026
GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 hormone to lower blood sugar levels, reduce appetite, and slow digestion. They are widely used in the treatment of type 2 diabetes and obesity, and are under study for other metabolic conditions. Common examples of this drug class include semaglutide, liraglutide, and tirzepatide.
Episodes
This week
Expert statements
Share of the conversation
Mentions of GLP-1 receptor agonist per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 28 | 0.01‰ | 1 |
| Oct 24 | 0.01‰ | 1 |
| Nov 13 | 0.02‰ | 2 |
| Nov 15 | 0.02‰ | 1 |
| Nov 16 | 0.03‰ | 1 |
| Nov 20 | 0.03‰ | 2 |
Email alert
Email me when GLP-1 receptor agonist comes up on a podcast
One email a week at most, with the new episodes that mention GLP-1 receptor agonist. Free, no account needed, unsubscribe in one click.
What experts have said about GLP-1 receptor agonist
145 statements · 79 positive · 50 negative · 7 mixed · 9 neutral
Joe Rogan recommends GLP-1s for morbid obesity over remaining severely obese.
“it's way better to lose all that weight and get on the GLP-1s than to be a guy who's like a day away. from a heart attack”
Open the episode · #2584 - Mike BakerListen at 15:55
GLP-1 drugs work for severe childhood obesity.
“The drugs work.”
Open the episode · Did gold stop working, Anthropic’s IPO explained & Pimp my Portfolio with Luke LaretiveListen at 10:35
Children may be more likely than adults to maintain GLP-1-related weight loss.
“Maybe with kids, you, you know, because it is in that formative stage, maybe they have a better chance of sticking to it afterwards.”
Open the episode · Did gold stop working, Anthropic’s IPO explained & Pimp my Portfolio with Luke LaretiveListen at 12:15
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
8 episodes featuring GLP-1 receptor agonist, newest first
- Nov 20, 2026
Wernicke’s often hides behind ordinary psychiatric symptomsPsychiatry & Psychotherapy PodcastNov 20, 2026 - Nov 16, 2026
Mitochondria do more than power cells—and supplements may not helpThe Peter Attia DriveNov 16, 2026 - Nov 15, 2026
Biotech investors weigh gene editing, MASH data and RAS riskBreaking BiotechNov 15, 2026 - Nov 13, 2026
Bongino links generational resentment to taxes and national resilienceThe Dan Bongino ShowNov 13, 2026 - Oct 24, 2026
Mind Pump links fast strength gains to sustainable trainingMind Pump: Raw Fitness TruthOct 24, 2026 - Sep 28, 2026
Medical evidence tests the gap between better numbers and better outcomesThe Curbsiders Internal Medicine PodcastSep 28, 2026